Breaking the Therapeutic Ceiling in Schizophrenia Care: What’s New?
The goal of this activity is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Psychiatry disorders.
ABMS Lifelong Learning CME Activity
Starting the Conversation: Practical Strategies for Integrating Cognitive Health Into Everyday Care
This activity is intended for healthcare professionals practicing in the United States who care for patients at risk for cognitive decline, including primary care practitioners, nurse practitioners, physician associates, pharmacists, general neurologists, geriatricians, as well as a secondary audience of…
ECHO Autism: Intense Behavior
ECHO Autism: Intense Behavior aims to increase access to best-practice assessment, diagnosis, and treatment for individuals on the autism spectrum with intense behavior such as severe emotional dysregulation, self-injurious behaviors, and physical aggression towards others. A variety of research studies…
Cognitive Check: A New Vital Sign? Advancing Cognitive Health Assessments in Specialty Care
The goal of this activity is to improve the knowledge, skills, and performance of learners to promote better practices in preserving brain health and preventing cognitive decline.
Approach to Scarring Alopecia
This Clinical Insights outlines the clinical characteristics, diagnostic approach, and therapeutic strategies for managing scarring alopecias.
Ethics Talk: Why Has US Health Research Shifted From Social and Environmental Factors to Genetics?
This activity is comprised of five multiple-choice questions based on the content of an AMA Journal of Ethics podcast about how US health research has shifted from social and environmental factors to genetics over the course of the mid-to-late 20th…
What Should Be Roles of Industry and the Public in Diagnostic Research?
Despite legislative attention from Congress in the 1980s, diagnostic research on rare diseases is not lucrative enough to garner sufficient private funding. The Undiagnosed Diseases Network supports diagnostic research and intervention innovation for patients with undiagnosed or rare conditions. This…
What Matters Ethically About How the UDN Has Changed Since Its Inception?
For persons living with an undiagnosed disease and their families, finding an accurate diagnosis can be a long and complex process. Having a rare condition that goes undiagnosed for a long period constitutes a significant part of these patients’ disease…
What Are Ethical Merits and Drawbacks of Viewing “Medical Mysteries” as Human Subject Research?
Patient-subjects’ participation in an Undiagnosed Diseases Network (UDN) protocol can afford access to innovative diagnostic techniques, especially in genomic medicine, which can shorten the time it takes to accurately diagnose a so-called “medical mystery.” But UDN research processes can be…
Management of Severe Refractory Asthma
This JAMA Insights explores the management of severe refractory asthma, including medications, access to specialists, and managing environmental triggers.
